Key Takeaway: Vanda Pharmaceuticals has announced its participation in the Stifel 2025 Healthcare Conference, scheduled for November 12, 2025, in New York City. The company will deliver a corporate presentation at 4:40 p.m. Eastern Time, which can be accessed live on its corporate website. Investors are encouraged to register in advance for the event.
Price reaction · baseline $4.44 (2025-11-05 close) · hit after-hours · clean, no other VNDA news in the window
day 0 close · peak
-0.7%
Market Sentiment Analysis
POSITIVE FACTORS
Participation in a prominent healthcare conference.
Opportunity to present corporate strategies to investors.
Increased visibility for Vanda Pharmaceuticals.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis
Full Press Release Details
WASHINGTON,Nov. 5, 2025/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:VNDA) today announced that the company will participate in the Stifel 2025 Healthcare Conference in New York City on Wednesday, November 12, 2025. A corporate presentation is scheduled for 4:40 p.m. Eastern Time.
The corporate presentation given at the Stifel conference may be accessed live on Vanda's corporate website,www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visitwww.vandapharma.comand follow us on X @vandapharma.